Horvath Clock (Pan-Tissue)

Epigenetic

DNA Methylation Clocks

The Horvath clock is the original multi-tissue epigenetic clock, published in 2013, which estimates biological age from methylation at 353 CpG sites across many tissue types. It measures intrinsic epigenetic age largely independent of blood cell composition. A longevity practice tracks it as a foundational, well-established reference point for cumulative biological aging.

What It Measures

Original multi-tissue epigenetic clock (2013); uses 353 CpG sites; measures intrinsic epigenetic age independent of blood composition

Optimal vs. Lab Range

Longevity Optimal

Biological age < chronological age

Target range for optimal health and longevity based on research.

Standard Lab

N/A — compared to chronological age

Population-based reference range from standard labs.

Why It Matters

A Horvath biological age above chronological age reflects intrinsic epigenetic age acceleration, while a younger biological age is the goal. Its defining feature is that it is pan-tissue and captures an intrinsic aging signal, making it less influenced by lifestyle and immune-cell shifts than newer clocks. That stability makes it a useful anchor but also means it tends to move less in response to short-term intervention than DunedinPACE. It differs from GrimAge, which is oriented toward mortality prediction, and from PhenoAge, which is built from clinical biomarkers. As one of the earliest clocks, it is a research tool that laid the groundwork for the field rather than a diagnostic test.

When Low

N/A — younger is the goal

When High

Intrinsic epigenetic age acceleration; less influenced by lifestyle than newer clocks

How to Optimize

Because the Horvath clock reflects intrinsic aging and responds less readily to short-term changes, the emphasis is on sustained foundational longevity habits: consistent exercise, metabolic and nutritional optimization, quality sleep, and stress management maintained over the long term. Meaningful shifts, if any, are best assessed over longer follow-up intervals. Investigational agents such as rapamycin and senolytics remain experimental and physician-directed. Biological-age testing is an emerging tool; interpretation and any interventions should be individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Strong evidence

Key Interventions

Foundational longevity protocols

Linked Compounds & Supplements

NMN

Resveratrol

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Buccal swab or whole blood (EDTA)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Annual

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Horvath Clock (Pan-Tissue).
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.